Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Big investors say US markets rally could prove short-lived
Post Content Post Views: 132
Dream Office Real Estate Investment Trust declares CAD 0.0833 dividend
Post Content Post Views: 133
Wells Fargo employees push for unionization amid labor disputes
Post Content Post Views: 123
Infosys and TK Elevator expand partnership
Post Content Post Views: 142
Purpose Fund Corp. – Purpose Enhanced Dividend Fund declares CAD 0.095 dividend
Post Content Post Views: 130
Holiday shopping: These stocks in the retail sector are seen as value plays
Post Content Post Views: 114